150 related articles for article (PubMed ID: 15694919)
1. Neuropeptide Y suppresses absence seizures in a genetic rat model.
Stroud LM; O'Brien TJ; Jupp B; Wallengren C; Morris MJ
Brain Res; 2005 Feb; 1033(2):151-6. PubMed ID: 15694919
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
3. Focal administration of neuropeptide Y into the S2 somatosensory cortex maximally suppresses absence seizures in a genetic rat model.
van Raay L; Jovanovska V; Morris MJ; O'Brien TJ
Epilepsia; 2012 Mar; 53(3):477-84. PubMed ID: 22220638
[TBL] [Abstract][Full Text] [Related]
4. Corticosterone increases spike-wave discharges in a dose- and time-dependent manner in WAG/Rij rats.
Schridde U; van Luijtelaar G
Pharmacol Biochem Behav; 2004 Jun; 78(2):369-75. PubMed ID: 15219779
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y affects thalamic reticular nucleus neuronal firing and network synchronization associated with suppression of spike-wave discharges.
Ali I; Gandrathi A; Zheng T; Morris MJ; O'Brien TJ; French C
Epilepsia; 2018 Jul; 59(7):1444-1454. PubMed ID: 29923603
[TBL] [Abstract][Full Text] [Related]
6. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
7. The effect of generalized absence seizures on the progression of kindling in the rat.
Onat FY; Aker RG; Gurbanova AA; Ateş N; van Luijtelaar G
Epilepsia; 2007; 48 Suppl 5():150-6. PubMed ID: 17910595
[TBL] [Abstract][Full Text] [Related]
8. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model.
Powell KL; Fitzgerald X; Shallue C; Jovanovska V; Klugmann M; Von Jonquieres G; O'Brien TJ; Morris MJ
Neurobiol Dis; 2018 May; 113():23-32. PubMed ID: 29414380
[TBL] [Abstract][Full Text] [Related]
10. The acute and chronic effect of vagus nerve stimulation in genetic absence epilepsy rats from Strasbourg (GAERS).
Dedeurwaerdere S; Vonck K; Van Hese P; Wadman W; Boon P
Epilepsia; 2005; 46 Suppl 5():94-7. PubMed ID: 15987260
[TBL] [Abstract][Full Text] [Related]
11. Rat models of genetic absence epilepsy: what do EEG spike-wave discharges tell us about drug effects?
van Luijtelaar EL; Drinkenburg WH; van Rijn CM; Coenen AM
Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():65-70. PubMed ID: 12575471
[TBL] [Abstract][Full Text] [Related]
12. Effects of carisbamate (RWJ-333369) in two models of genetically determined generalized epilepsy, the GAERS and the audiogenic Wistar AS.
François J; Boehrer A; Nehlig A
Epilepsia; 2008 Mar; 49(3):393-9. PubMed ID: 17822432
[TBL] [Abstract][Full Text] [Related]
13. Long-term valproate treatment increases brain neuropeptide Y expression and decreases seizure expression in a genetic rat model of absence epilepsy.
Elms J; Powell KL; van Raay L; Dedeurwaerdere S; O'Brien TJ; Morris MJ
PLoS One; 2013; 8(9):e73505. PubMed ID: 24039965
[TBL] [Abstract][Full Text] [Related]
14. The role of the inherited genetic background on the consequences of lithium-pilocarpine status epilepticus: study in Genetic Absence Epilepsy Rats from Strasbourg and Wistar audiogenic rats.
Hanaya R; Koning E; Ferrandon A; Nehlig A
Neurobiol Dis; 2008 Sep; 31(3):451-8. PubMed ID: 18638555
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy.
Russo E; Citraro R; De Fazio S; Marra R; Gitto R; Chimirri A; De Sarro G; Di Paola ED
Epilepsy Behav; 2008 Aug; 13(2):295-9. PubMed ID: 18514580
[TBL] [Abstract][Full Text] [Related]
16. Polygenic control of idiopathic generalized epilepsy phenotypes in the genetic absence rats from Strasbourg (GAERS).
Rudolf G; Bihoreau MT; Godfrey RF; Wilder SP; Cox RD; Lathrop M; Marescaux C; Gauguier D
Epilepsia; 2004 Apr; 45(4):301-8. PubMed ID: 15030491
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of carbamazepine aggravation of absence seizures.
Liu L; Zheng T; Morris MJ; Wallengren C; Clarke AL; Reid CA; Petrou S; O'Brien TJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):790-8. PubMed ID: 16895979
[TBL] [Abstract][Full Text] [Related]
18. Electroencephalographic and behavioral effects of intracerebroventricular or intraperitoneal injections of toxic honey extract in adult Wistar rats and GAERS.
Kuru P; Torun M; Halac HM; Temiz G; Iskender E; Karamahmutoglu T; Idrizoglu MG; Onat FY
Neurol Sci; 2014 Dec; 35(12):1903-8. PubMed ID: 25120202
[TBL] [Abstract][Full Text] [Related]
19. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
20. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
